These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6096466)

  • 1. [Chemo-endocrine-immuno therapy with adriamycin, tamoxifen and OK-432 for advanced breast cancer].
    Sawai K; Takahashi S; Izumi H; Kato G; Takenaka A; Shinbata O; Tokuda H
    Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1315-20. PubMed ID: 6096466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of CAF'-endocrine therapy on advanced and recurrent breast cancer].
    Une Y; Sato Y; Kagaya H; Miyata S; Matsuoka S; Uchino J; Yakura Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2778-81. PubMed ID: 6548892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination therapy with low dose adriamycin for advanced or recurrent breast cancer. Hokkaido Breast Cancer Treatment Study Group].
    Uchino J; Hata Y; Sasaki F; Takahashi H; Ogita M; Ohira S; Nakanishi M; Taguchi K; Inoue T; Konno T
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2157-64. PubMed ID: 8239680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tamoxifen plus tegafur plus low-dose adriamycin in the treatment of advanced breast cancer in an outpatient basis].
    Shiba E; Koyama H; Noguchi S; Nishizawa Y; Iwanaga T; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2196-201. PubMed ID: 3128615
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chemo-endocrine therapy in recurrent breast cancer].
    Kawaura Y; Hashizume Y; Ishida K; Katada S; Hirano M; Yamada T; Iwa T
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):68-72. PubMed ID: 3701167
    [No Abstract]   [Full Text] [Related]  

  • 6. [Local treatment of locally recurrent breast cancers].
    Asaishi K; Okazaki M; Hayasaka H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1325-30. PubMed ID: 3382202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer].
    Imajo K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Ozeki H; Nagamine D; Shinagawa K; Fukutani H
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):121-6. PubMed ID: 3122665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on chemo-immunotherapy for advanced and recurrent carcinoma of the breast].
    Kikuchi K; Takahashi N
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1476-81. PubMed ID: 3925888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
    Inoue H; Kobayashi H; Kajiya Y; Hidaka H; Ikeda K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):620-2. PubMed ID: 3006597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
    Sautter-Bihl ML
    Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
    Kiman K; Suzuki S; Satomi T; Sakonji M; Nihei M; Tanaka T; Kimijima I; Abe R
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2445-52. PubMed ID: 7944490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].
    Nomura Y; Abe O; Izuo M; Inoue K; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1863-71. PubMed ID: 3382238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
    Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Scottish trial of adjuvant tamoxifen in node-negative breast cancer. Scottish Cancer Trials Breast Group.
    Stewart HJ
    J Natl Cancer Inst Monogr; 1992; (11):117-20. PubMed ID: 1320920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
    Fujimori M; Sugenoya A; Kobayashi S; Masuda H; Komatsu M; Takahashi S; Shimizu T; Tsuchiya S; Iida F
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2760-3. PubMed ID: 2551219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen in the treatment of advanced breast cancer. Clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Chantarakul N; Thansakul A
    J Med Assoc Thai; 1986 Feb; 69(2):96-102. PubMed ID: 3011939
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining the use of endocrine therapy for ductal carcinoma in situ.
    Morrow M
    J Clin Oncol; 2012 Apr; 30(12):1249-51. PubMed ID: 22393104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.